A number of firms have modified their ratings and price targets on shares of Astera Labs (NASDAQ: ALAB) recently:
- 8/18/2026 – Astera Labs had its “hold (c)” rating reaffirmed by Weiss Ratings.
- 8/17/2026 – Astera Labs was upgraded by Northland Securities from “market perform” to “outperform”. They now have a $350.00 price target on the stock.
- 8/11/2026 – Astera Labs was upgraded by Zacks Research from “hold” to “strong-buy”.
- 8/5/2026 – Astera Labs had its price target lowered by TD Cowen from $425.00 to $375.00. They now have a “hold” rating on the stock.
- 8/5/2026 – Astera Labs had its “buy” rating reaffirmed by Roth Capital. They now have a $450.00 price target on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Royal Bank Of Canada from $425.00 to $500.00. They now have an “outperform” rating on the stock.
- 8/5/2026 – Astera Labs had its “neutral” rating reaffirmed by UBS Group AG. They now have a $425.00 price target on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Jefferies Financial Group Inc. from $270.00 to $450.00. They now have a “buy” rating on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Needham & Company LLC from $260.00 to $425.00. They now have a “buy” rating on the stock.
- 8/3/2026 – Astera Labs had its price target raised by Morgan Stanley to $335.00. They now have an “overweight” rating on the stock.
- 7/31/2026 – Astera Labs had its price target raised by Susquehanna from $230.00 to $275.00. They now have a “neutral” rating on the stock.
- 7/29/2026 – Astera Labs had its “buy” rating reaffirmed by Citigroup Inc..
- 7/20/2026 – Astera Labs had its price target raised by Barclays PLC from $200.00 to $325.00. They now have an “equal weight” rating on the stock.
- 7/13/2026 – Astera Labs had its price target raised by TD Cowen from $225.00 to $425.00. They now have a “hold” rating on the stock.
- 6/29/2026 – Astera Labs had its price target raised by UBS Group AG from $205.00 to $400.00. They now have a “neutral” rating on the stock.
Insiders Place Their Bets
In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 419,244 shares of company stock worth $163,135,169 in the last three months. Corporate insiders own 10.40% of the company’s stock.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Astera Labs Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs Inc and related companies with MarketBeat.com's FREE daily email newsletter.
